#USA #Canaccord Genuity #Castle Biosciences #Friendwood #CSTL

Castle Biosciences to Present at Canaccord Genuity 46th Annual Growth Conference

Castle Biosciences, Inc. (Nasdaq: CSTL), an innovative leader in health diagnostics, has announced its participation in the highly anticipated Canaccord Genuity 46th Annual Growth Conference. This event is scheduled for Wednesday, August 12, 2026, at 11:30 AM Eastern Time. The executive management team of Castle Biosciences will provide a comprehensive overview of the company's operations and recent advancements in their field.

Castle Biosciences specializes in developing advanced diagnostic tests that help guide patient care, particularly in the realms of dermatologic and gastroenterological diseases. The company's solutions are designed to empower both patients and clinicians, significantly enhancing the decision-making process for treatment options. Their mission revolves around delivering personalized, clinically actionable insights that improve disease management and patient outcomes.

Live Presentation and Webcast Details

The presentation will be accessible to those interested through a live audio webcast that can be found on Castle Biosciences' official website at https://ir.castlebiosciences.com/news-events/ir-events. Following the live event, a recorded version of the presentation will also be made available for anyone who is unable to tune in at the scheduled time. This ensures that stakeholders and interested parties can review the critical information shared at this important conference, regardless of their availability during the live session.

About Castle Biosciences

Castle Biosciences is recognized for its pioneering approach in the diagnostics sector, particularly for its focus on innovative tests that directly influence patient care. Their offerings include various specialized tests such as DecisionDx-Melanoma, DecisionDx-CMSeq, and many others that cater to different medical needs. The company's products are trademarked under Castle Biosciences, reinforcing its commitment to providing reliable and effective solutions in the health industry.

With a firm belief in the power of science-guided treatment strategies, Castle Biosciences places significant emphasis on rigorous research and development efforts. The company's tests are designed not only to determine the most appropriate treatment plans but also to deliver peace of mind to patients and healthcare providers.

Castle Biosciences continues to expand its influence and capabilities, aiming to set new standards in patient care through cutting-edge molecular tests and superior diagnostic solutions. The company's presence at the Canaccord Genuity Conference is a testament to its ongoing commitment to innovation and excellence in the healthcare sector.

For additional details and to stay updated on Castle Biosciences’ journey, interested individuals can visit their website or connect through various social media platforms such as LinkedIn, Instagram, Facebook, and X. Through these channels, Castle Biosciences shares insights, updates, and information that further their objective of improving patient care around the world.

Join the Castle Biosciences team at the Canaccord Genuity 46th Annual Growth Conference to glean valuable insights into the future of health diagnostics and the impact of innovative testing solutions!